{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:49:56Z","timestamp":1759333796434,"version":"build-2065373602"},"reference-count":112,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010718","name":"Foundation for Biomedical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.addr.2007.04.015","type":"journal-article","created":{"date-parts":[[2007,8,10]],"date-time":"2007-08-10T14:08:49Z","timestamp":1186754929000},"page":"1213-1221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation systems for anti-HCV drugs"],"prefix":"10.1016","volume":"59","author":[{"given":"Kohji","family":"Moriishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2007.04.015_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/095632020301400601","article-title":"Mechanisms of hepatitis C virus infection","volume":"14","author":"Moriishi","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.addr.2007.04.015_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.addr.2007.04.015_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2007.04.015_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.addr.2007.04.015_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8278(99)80377-8","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"31","author":"Mondelli","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.addr.2007.04.015_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.addr.2007.04.015_bib7","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/jvi.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib8","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/jvi.67.7.4017-4026.1993","article-title":"NS3 is a serine protease required for processing of hepatitis C virus polyprotein","volume":"67","author":"Tomei","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib9","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1021\/bi047408j","article-title":"Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells","volume":"44","author":"Hamill","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2007.04.015_bib10","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","article-title":"Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex","volume":"76","author":"Egger","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib11","doi-asserted-by":"crossref","first-page":"13038","DOI":"10.1073\/pnas.0405152101","article-title":"Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication","volume":"101","author":"Evans","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib12","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2007.04.015_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","article-title":"Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"15","author":"Behrens","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2007.04.015_bib14","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1128\/JVI.79.21.13473-13482.2005","article-title":"Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B","volume":"79","author":"Hamamoto","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib15","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1038\/sj.emboj.7601367","article-title":"Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90","volume":"25","author":"Okamoto","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2007.04.015_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.1999.9893","article-title":"Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein","volume":"263","author":"Tu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.addr.2007.04.015_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.addr.2007.04.015_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2007.04.015_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.addr.2007.04.015_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.addr.2007.04.015_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2007.04.015_bib22","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib23","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/JVI.72.4.2589-2599.1998","article-title":"Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles","volume":"72","author":"Bassett","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib24","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2007.04.015_bib25","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.79.9.5774-5785.2005","article-title":"Scavenger receptor class B type I and hepatitis C virus infection of primary Tupaia hepatocytes","volume":"79","author":"Barth","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1172\/JCI0213011","article-title":"Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection","volume":"109","author":"Zhao","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2007.04.015_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/viro.1998.9127","article-title":"Transmission of hepatitis C virus infection to tree shrews","volume":"244","author":"Xie","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.addr.2007.04.015_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2007.04.015_bib29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.21209","article-title":"Anti-HCV therapies in chimeric scid-Alb\/uPA mice parallel outcomes in human clinical application","volume":"43","author":"Kneteman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2007.04.015_bib30","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1128\/JVI.76.11.5326-5338.2002","article-title":"Genetic analysis of sequences in the 3\u2032 nontranslated region of hepatitis C virus that are important for RNA replication","volume":"76","author":"Friebe","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib31","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1128\/JVI.75.24.12047-12057.2001","article-title":"Sequences in the 5\u2032 nontranslated region of hepatitis C virus required for RNA replication","volume":"75","author":"Friebe","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib32","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1128\/JVI.75.18.8516-8523.2001","article-title":"Effect of alpha interferon on the hepatitis C virus replicon","volume":"75","author":"Guo","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib33","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.212532699","article-title":"Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees","volume":"99","author":"Bukh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib34","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/JVI.77.9.5352-5359.2003","article-title":"Replication studies using genotype 1a subgenomic hepatitis C virus replicons","volume":"77","author":"Gu","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib35","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/JVI.77.5.3181-3190.2003","article-title":"Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture","volume":"77","author":"Blight","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","article-title":"Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon","volume":"125","author":"Kato","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2007.04.015_bib37","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JVI.73.4.2641-2649.1999","article-title":"The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum","volume":"73","author":"Cocquerel","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib38","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/JVI.72.3.2183-2191.1998","article-title":"A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2","volume":"72","author":"Cocquerel","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/viro.2001.0971","article-title":"Characterization of pseudotype VSV possessing HCV envelope proteins","volume":"286","author":"Matsuura","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.addr.2007.04.015_bib40","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.1128\/JVI.76.22.11775-11779.2002","article-title":"Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus\/HCV pseudotype","volume":"76","author":"Burioni","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib41","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/JVI.76.14.6865-6872.2002","article-title":"Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins","volume":"76","author":"Buonocore","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2007.04.015_bib43","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib45","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib46","doi-asserted-by":"crossref","first-page":"22371","DOI":"10.1074\/jbc.M311120200","article-title":"Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells","volume":"279","author":"Date","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.79.1.592-596.2005","article-title":"Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon","volume":"79","author":"Kato","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib48","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.0511218103","article-title":"Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro","volume":"103","author":"Lindenbach","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib49","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib51","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.08.002","article-title":"Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients","volume":"127","author":"Hinrichsen","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2007.04.015_bib52","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1128\/JVI.78.14.7352-7359.2004","article-title":"Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061","volume":"78","author":"Thibeault","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.20612","article-title":"Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C","volume":"41","author":"Reiser","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2007.04.015_bib54","doi-asserted-by":"crossref","first-page":"17508","DOI":"10.1074\/jbc.M313020200","article-title":"In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms","volume":"279","author":"Lin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib55","doi-asserted-by":"crossref","first-page":"36784","DOI":"10.1074\/jbc.M506462200","article-title":"In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061","volume":"280","author":"Lin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib56","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1128\/AAC.50.5.1813-1822.2006","article-title":"VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells","volume":"50","author":"Lin","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.04.015_bib57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2006.07.013","article-title":"Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study","volume":"131","author":"Reesink","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2007.04.015_bib58","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1021\/jm060325b","volume":"49","author":"Venkatraman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2005.12.003","article-title":"Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034","volume":"70","author":"Tong","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2007.04.015_bib60","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/AAC.00433-06","article-title":"General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2\u2032-modified nucleotide analogues","volume":"50","author":"Dutartre","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.04.015_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.antiviral.2006.06.001","article-title":"Recent development of therapeutics for chronic HCV infection","volume":"71","author":"Huang","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2007.04.015_bib62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/337476a0","article-title":"Cyclophilin and peptidyl-prolyl cis\u2013trans isomerase are probably identical proteins","volume":"337","author":"Fischer","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/341755a0","article-title":"A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin","volume":"341","author":"Siekierka","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib64","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.143.5.1580","article-title":"FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin","volume":"143","author":"Siekierka","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2007.04.015_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-5793(94)80608-X","article-title":"A novel peptidyl-prolyl cis\/trans isomerase from Escherichia coli","volume":"343","author":"Rahfeld","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2007.04.015_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin\u2013cyclosporin A and FKBP\u2013FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.addr.2007.04.015_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-1119(95)00216-S","article-title":"Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs","volume":"160","author":"Lam","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.addr.2007.04.015_bib68","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/sj.emboj.7600739","article-title":"Bcl-2 regulator FKBP38 is activated by Ca2+\/calmodulin","volume":"24","author":"Edlich","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2007.04.015_bib69","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.M600452200","article-title":"The specific FKBP38 inhibitor N-(N\u2032,N\u2032-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia","volume":"281","author":"Edlich","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygeno.2003.07.001","article-title":"Fkbp8: novel isoforms, genomic organization, and characterization of a forebrain promoter in transgenic mice","volume":"83","author":"Nielsen","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.addr.2007.04.015_bib71","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1242\/dev.01122","article-title":"FKBP8 is a negative regulator of mouse sonic hedgehog signaling in neural tissues","volume":"131","author":"Bulgakov","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.addr.2007.04.015_bib72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncb894","article-title":"Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis","volume":"5","author":"Shirane","year":"2003","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.addr.2007.04.015_bib73","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1074\/jbc.274.5.2682","article-title":"The common tetratricopeptide repeat acceptor site for steroid receptor-associated immunophilins and hop is located in the dimerization domain of Hsp90","volume":"274","author":"Carrello","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib74","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1073\/pnas.241510898","article-title":"Host cell factor requirement for hepatitis C virus enzyme maturation","volume":"98","author":"Waxman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib75","doi-asserted-by":"crossref","first-page":"45306","DOI":"10.1074\/jbc.M206822200","article-title":"Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis","volume":"277","author":"Momose","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib76","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JVI.01917-06","article-title":"Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits","volume":"81","author":"Naito","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib77","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1128\/JVI.79.16.10740-10749.2005","article-title":"Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus","volume":"79","author":"Burch","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib78","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1128\/JVI.79.11.6827-6837.2005","article-title":"The cellular chaperone heat shock protein 90 facilitates Flock House virus RNA replication in Drosophila cells","volume":"79","author":"Kampmueller","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1101\/gad.1505307","article-title":"Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance","volume":"21","author":"Geller","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2007.04.015_bib80","series-title":"Virology","article-title":"Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses","author":"Connor","year":"2007"},{"key":"10.1016\/j.addr.2007.04.015_bib81","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1073\/pnas.93.3.1060","article-title":"Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase","volume":"93","author":"Hu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/emboj\/16.1.59","article-title":"Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids","volume":"16","author":"Hu","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2007.04.015_bib83","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0092-8674(93)90637-6","article-title":"Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B","volume":"73","author":"Luban","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.addr.2007.04.015_bib84","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02777","article-title":"Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1","volume":"430","author":"Sayah","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib85","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2007.04.015_bib86","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)99079-4","article-title":"S-cyclophilin. New member of the cyclophilin family associated with the secretory pathway","volume":"266","author":"Caroni","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib87","doi-asserted-by":"crossref","first-page":"16537","DOI":"10.1016\/S0021-9258(19)89421-8","article-title":"Characterization of surface binding sites for cyclophilin B on a human tumor T-cell line","volume":"269","author":"Allain","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib88","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1016\/S0021-9258(18)99078-2","article-title":"A novel secreted cyclophilin-like protein (SCYLP)","volume":"266","author":"Spik","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2007.04.015_bib89","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1210\/mend.14.8.0508","article-title":"Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation","volume":"14","author":"Rycyzyn","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.addr.2007.04.015_bib90","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/emboj\/cdg045","article-title":"Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells","volume":"22","author":"Cohen","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2007.04.015_bib91","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1128\/JVI.80.9.4510-4520.2006","article-title":"Diverse effects of cyclosporine on hepatitis C virus strain replication","volume":"80","author":"Ishii","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib92","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes","volume":"38","author":"Watashi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2007.04.015_bib93","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1073\/pnas.0511136103","article-title":"The HIV lipidome: a raft with an unusual composition","volume":"103","author":"Brugger","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib94","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1128\/JVI.79.21.13673-13684.2005","article-title":"Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2006.07.003","article-title":"Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef","volume":"355","author":"Giese","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.addr.2007.04.015_bib96","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1074\/mcp.M600121-MCP200","article-title":"Modification of host lipid raft proteome upon hepatitis C virus replication","volume":"5","author":"Mannova","year":"2006","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.addr.2007.04.015_bib97","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.01439-06","article-title":"The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production","volume":"80","author":"Oomens","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nchembio742","article-title":"Host sphingolipid biosynthesis as a target for hepatitis C virus therapy","volume":"1","author":"Sakamoto","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2007.04.015_bib99","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2007.04.015_bib101","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","article-title":"Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets","volume":"94","author":"Barba","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 7","key":"10.1016\/j.addr.2007.04.015_bib102","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib103","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0607312104","article-title":"Critical role of PA28 gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis","volume":"104","author":"Moriishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib104","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1128\/JVI.77.19.10237-10249.2003","article-title":"Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein","volume":"77","author":"Moriishi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib105","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1128\/JVI.01684-06","article-title":"E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein","volume":"81","author":"Shirakura","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib106","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.virol.2004.03.034","article-title":"Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts","volume":"324","author":"Aizaki","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.addr.2007.04.015_bib107","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1128\/JVI.78.7.3480-3488.2004","article-title":"Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib108","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1128\/JVI.77.7.4160-4168.2003","article-title":"Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2","volume":"77","author":"Shi","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2007.04.015_bib109","doi-asserted-by":"crossref","first-page":"15865","DOI":"10.1073\/pnas.2237238100","article-title":"Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation","volume":"100","author":"Ye","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2007.04.015_bib110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti-HCV profiles of statins and their potential for combination therapy with interferon","volume":"44","author":"Ikeda","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.addr.2007.04.015_bib111","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2005.04.004","article-title":"Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication","volume":"18","author":"Wang","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.addr.2007.04.015_bib112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(99)01211-9","article-title":"Identification of a novel Skp2-like mammalian protein containing F-box and leucine-rich repeats","volume":"459","author":"Ilyin","year":"1999","journal-title":"FEBS Lett."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:31:30Z","timestamp":1759206690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X07001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":112,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0169409X07001275"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2007.04.015","relation":{},"ISSN":["0169-409X"],"issn-type":[{"type":"print","value":"0169-409X"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation systems for anti-HCV drugs","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2007.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}